💉To ALS patients in the world, we hope to deliver Japan-originated ALS treatment 💉To ALS patien Tuesday April 10th, 2018By Tokio X'press Drugs, Pharmaceutical mt-pharma
💊Mitsubishi Tanabe Pharma and Hitachi Utilize AI Technology to Begin Collaborative Creation for Improving Efficiency of Clinical Trials for New Drug Development Tuesday March 27th, 2018By Tokio X'press Drugs, AI, Pharmaceutical mt-pharma
💊Completion of Acquisition of NeuroDerm (100% Ownership) 20171018 Thursday October 19th, 2017By Tokio X'press JPN, Pharmaceutical mt-pharma
💊Mitsubishi Tanabe Pharma Corporation] Notice regarding acquisition of manufacturing and sales approval for Rupafin tablets Allergy treatment agent with new mechanism of action shows strong effectiveness with dual action (anti-PAF and antihistamine action) 20170927 💊Mitsubishi Tanabe Pha Thursday September 28th, 2017By Tokio X'press JPN, Pharmaceutical mt-pharma
